A benchmarking study of feature screening approaches across type 1 diabetes omics studies classification settings
PLOS Computational Biology · 12.08.2026 · 22 (8) · e1014625
DOI: 10.1371/journal.pcbi.1014625 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, online erschienen am 12.08.2026. Verfasst von Erik D VonKaenel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biological Science Division, Pacific Northwest National Laboratory, Richland, Washington, United States of America. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, National Institutes of Health.
Themen: Diabetes mellitus
Abstract (Originalsprache)
In recent years, high dimensional omics analyses have become more commonplace for investigating complex biological systems. Typically, these studies attempt to identify key biomolecules associated with a particular biological process. Often, machine learning (ML) is used to identify these biomolecules, typically by learning which biomolecules are highly predictive of a treatment, biological outcome, or phenotype. A major challenge of applying ML to high throughput omics is overcoming noise when sample size is limited and unbalanced with respect to tens of thousands of biomolecules measured. Thus, feature selection (the process of reducing the number of predictors) is both a critical and common step in the ML analysis pipeline. While much attention has been given to embedding and wrapping techniques for feature selection in the omics space, filter-based methods for model-free feature selection have appealing theoretical properties. This manuscript evaluates sure screening, a class of filter-based feature selection methods which provide analytical guarantees for true feature set retention. Here, we cover existing feature screening methods based on the sure screening principal, available software, methods to improve feature screening, and contextualize feature screening in the larger discussion of feature selection for omics data analysis. Additionally, a suite of model-free sure screening approaches is applied and compared for several omics biomedical applications in a ML classification context. We identified BcorSIS as the most effective and computationally efficient screening method across various omics datasets, consistently outperforming others like CSIS and DCSIS in runtime.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Biological Science Division, Pacific Northwest National Laboratory, Richland, Washington, United States of America.
ORCID-Profile: Lisa M Bramer, Bobbie-Jo M Webb-Robertson
Förderung
- NIDDK NIH HHS
- NCATS NIH HHS
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
VonKaenel, E. D., Bramer, L. M., Flores, J. E., Metz, T. O., Nakayasu, E. S., & Webb-Robertson, B. M. (2026). A benchmarking study of feature screening approaches across type 1 diabetes omics studies classification settings. PLOS Computational Biology, 22(8), e1014625. https://doi.org/10.1371/journal.pcbi.1014625
Vancouver
VonKaenel ED, Bramer LM, Flores JE, Metz TO, Nakayasu ES, Webb-Robertson BM. A benchmarking study of feature screening approaches across type 1 diabetes omics studies classification settings. PLOS Computational Biology. 2026;22(8):e1014625. doi:10.1371/journal.pcbi.1014625
BibTeX
@article{VonKaenel2026,
author = {VonKaenel, Erik D and Bramer, Lisa M and Flores, Javier E and Metz, Thomas O and Nakayasu, Ernesto S and Webb-Robertson, Bobbie-Jo M},
title = {A benchmarking study of feature screening approaches across type 1 diabetes omics studies classification settings},
journal = {PLOS Computational Biology},
year = {2026},
volume = {22},
number = {8},
pages = {e1014625},
doi = {10.1371/journal.pcbi.1014625}
}
EUVIMED